Chiroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chiroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Reynolds who wrote (16)	2/15/1998 8:01:00 AM
From: James Reynolds	Read Replies (1) of 69

Chiroscience is suffering form a very nervous UK biotech sector. A number of high profile failures/setbacks/delays etc (eg. Celltech, Biocompatibles, Scotia) has damaged sentiment severely. Unfortunately, all UK biotechs are being tarred with the same brush such that even companies which have not disappointed ( eg. Chiroscience, Cortecs) have seen their share price fall back. Investors are much more cautious and even great news like Chiroscience's Bristol Myers Squibb deal is getting a muted response from the stock market. However, later in 98 there is the possibility of product approvals for Chiroscience (Chirocaine) and Cortecs (Macritonin) which would be an enormous boost for the sector. .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next